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Jonathan Rubin, MD, PhDt 
Congenital cystic adenomatoid malformation of 
the lung is a developmental abnormality charac- 
terized by abnormal proliferation of terminal 
bronchioles forming cysts of varying sizes. Ex- 
tensive lesions are associated with a poor prog- 
nosis due to the development of nonimmune hy- 
drops and/or pulmonary hypoplasia. The advent 
of high-resolution ultrasonography has made it 
possible to identify these lesions during the ante- 
natal period. With the prenatal identification of 
cystic adenomatoid malformations comes the po- 
tential for in utero intervention to modify the 
natural history of this process and prevent the 
development of hydrops and pulmonary hypopla- 
sia. An instance of successful intrauterine treat- 
ment of congenital cystic adenomatoid malfor- 
mation is presented. 
CASE REPORT 
A 32-year-old primagravida was referred at  28 
weeks, menstrual age, because of a cystic chest 
mass noted on ultrasound examination. Ultra- 
sound evaluation revealed a 28-week fetus with 
a 4 cm X 3.5 cm X 2.5 cm unilocular cystic mass 
filling the left side of the fetal thorax, displacing 
the heart into the right hemithorax (Figure 1). 
The fetal stomach was present in the appropriate 
location and the diaphragm appeared intact. No 
evidence of fetal hydrops was identified. Based 
on the ultrasound findings, congenital cystic ad- 
enomatoid malformation was felt to  be the most 
likely diagnosis followed by pulmonary seques- 
tration or bronchogenic cyst. 
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Given the relative size of the cyst, the fetus 
was felt to be at significant risk for pulmonary 
hypoplasia. Likewise, with the degree of medias- 
tinal shift present, there was concern that car- 
diac function could ultimately be compromised 
leading to nonimmune hydrops. These concerns 
were discussed with the parents, who strongly 
desired that an attempt at intrauterine therapy 
be made. It was therefore planned to proceed 
with fetal thoracentesis followed by interval 
placement of an indwelling shunt only if there 
was significant fluid reaccumulation. 
Cessation of fetal movement was achieved by 
injecting 0.3 mg of pancuronium bromide into 
the fetal thigh under ultrasound guidance 
(Acuson 128). An 18-gauge Tuohy needle was 
then guided into the center of the cyst. Immedi- 
ately on removing the stylet, there was brisk 
flow of clear viscous fluid. After removal of '22 
mL of fluid, the cyst had completely disappeared 
and heart shifted back to the left. An umbilical 
vein blood sample for cytogenetic analysis was 
then obtained from the placental insertion of the 
cord. Fetal heart activity remained stable 
throughout the procedures. 
Analysis of the fluid included a cell count and 
differential with 545 red blood cells and 355 
white blood cellskmm with the differential show- 
ing 13% segs, 36% lymphs, and 51% histiocytes. 
Protein was less than 1.0 g/dL. Cytologic exami- 
nation of the fluid revealed numerous histio- 
cytes, karyorrhectic debris, and ciliated colum- 
nar epithelial cells. Cytogenetic analysis of the 
fetal blood sample yielded a normal 46,XY kary- 
otype. 
Serial follow-up ultrasound scans were ob- 
tained. On the first day following the procedure 
there was only minimal fluid reaccumulation. 
The cyst had increased in size to  approximately 2 
cm four days following the thoracentesis. The 
cyst exhibited minimal expansion during the re- 
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FIGURE 1. Transverse view of the fetal chest. The heart (H) is displaced into the right hemithorax by the 
cystic adenomatoid malformation (C). 
mainder of the pregnancy and actually occupied 
a relatively smaller proportion of the thorax. 
A 3440 g male infant with Apgar scores of 7 at 
one minute and 9 at  five minutes was delivered 
at 40 weeks. Careful examination revealed no 
evidence of trauma from the thoracentesis. The 
infant had no evidence of respiratory compro- 
mise in the nursery. Chest radiographs and com- 
puted tomography scans verified the presence of 
a cystic mass in the region of the left upper lobe. 
A left upper lobectomy was performed on the 
fourth day of life. The specimen weighed 30 g 
and contained a 4 cm x 3 cm x 2.5 cm smooth- 
walled unilocular cyst. Microscopic examination 
verified the diagnosis of Type I cystic adenoma- 
toid malformation. The infant was discharged 
home on the seventh postoperative day. 
DISCUSSION 
Congenital cystic adenomoid malformations 
have typically been detected in infancy at  the 
time of evaluation of respiratory distress or re- 
current respiratory infections. The advent of 
high-resolution ultrasonography has shifted the 
ability to diagnose these lesions into the antena- 
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tal period with the potential for intrauterine in- 
tervention. Although fetuses with macrocystic 
lesions have a more favorable prognosis than 
those with microcystic lesions,l there is cur- 
rently no reliable marker to  indicate which fe- 
tuses will be benefited by in utero decompression 
(short of those instances in which hydropic 
change is present). 
A review of the literature yielded 16 other re- 
ported instances of antenatally detected macro- 
cystic congenital cystic adenomatoid malforma- 
tions with 12 surviving infants. In three in- 
stances, intrauterine drainage procedures were 
performed with favorable outcomes. Adzick et 
al.' performed thoracentesis at 34 and 36 weeks, 
menstrual age, but noted reaccumulation of the 
fluid in less than 16 hours. They concluded that 
thoracentesis of macrocystic lesions in utero did 
not appear to provide lasting decompression of 
normal lung tissue. Nicolaides et aL2 accom- 
plished chronic drainage of a cyst due to Type I 
cystic adenomatoid malformation by placing a 
double pigtain catheter between the cyst and 
amniotic fluid cavities at  24 weeks. Clark et aL3 
reported resolution of fetal hydrops following 
drainage of a cystic adenomatoid malformation 
(CAM). The cyst was initially drained by thora- 
centesis, but reexpanded within 48 hours. The 
cyst was then chronically drained with an in- 
dwelling catheter with complete resolution of the 
fetal hydrops documented within three weeks. 
The major dilemma confronted in managing 
these lesions is knowing whether intervention 
prior to the onset of hydrops is truly altering the 
ultimate outcome. Although all reported in- 
stances of intrauterine drainage to date have 
been associated with survival of the infant, there 
are reports of equally dramatic lesions that have 
not been treated with intrauterine drainage that 
have ultimately had a favorable o ~ t c o m e . ~  This 
is surprising in view of the severity of pulmo- 
nary hypoplasia seen with other space-occupying 
lesions of the fetal chest such as diaphragmatic 
hernia. 
Despite the initial complete drainage of the 
cyst in this instance, the dimensions of the cyst 
in the surgical specimen were essentially identi- 
cal to  the ultrasound measurements prior to  tho- 
racentesis. Based on the outcome of this patient, 
it does not appear that in utero decompression of 
Type I cystic adenomatoid malformation is nec- 
essary in the absence of hydrops. 
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